共 23 条
[1]
Griffin D(2021)The importance of understanding the stages of COVID-19 in treatment and trials AIDS Rev 23 40-47
[2]
Brennan-Rieder D(2021)Repurposed antiviral drugs for COVID-19 - interim WHO Solidarity trial results N Engl J Med 384 497-511
[3]
Ngo B(2020)Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect? Clin Infect Dis 71 2736-2743
[4]
Clancy C(2021)Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study J Antimicrob Chemother 76 1078-1084
[5]
Hong NM(2017)Patterns in bacterial- and viral-induced immunosuppression and secondary infections in the ICU Shock 47 5-12
[6]
Falcone M(2014)The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence 5 45-56
[7]
Tiseo G(2021)Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia Am J Resp Crit Care Med 204 921-932
[8]
Giordano C(2021)Tocilizumab for treatment of mechanically ventilated patients with COVID-19 Clin Infect Dis 73 e445-e454
[9]
Koch R(undefined)undefined undefined undefined undefined-undefined
[10]
Kox M(undefined)undefined undefined undefined undefined-undefined